Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023

Rhea-AI Summary

Stevanato Group to release Q3 2023 financial results and host conference call

Positive

• Stevanato Group S.p.A. will issue financial results for Q3 2023 on October 31, 2023.
• Conference call and webcast scheduled to discuss financial results.
• Participants can pre-register for the conference call and gain immediate access using the provided link.

Negative

• None.

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the third quarter of 2023 on Tuesday, October 31, 2023, at 6:30 a.m. (ET).

Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Tuesday, October 31, 2023 to discuss financial results. During the call, management will refer to a slide presentation which will be available on the morning of the call on the “Financial Results” page under the Company's Investor Relations section of its website.

Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link:
https://services.choruscall.it/DiamondPassRegistration/register?confirmationNumber=4544003&linkSecurityString=514976446

Webcast: A live, listen-only webcast of the call will be available at the following link:
https://87399.choruscall.eu/links/stevanato231031.html

Dial in: Those who are unable to pre-register may dial in by calling:

	Italy:		+39 02 802 09 11
	United Kingdom:		+44 1 212 818004
	United States:		+1 718 705 8796
	United States Toll Free:		+1 855 265 6958

Participants who wish to ask questions during the call are encouraged to use an HD webphone link:
https://hditalia.choruscall.com/?$Y2FsbHR5cGU9MiZpbmZvPWNvbXBhbnk=

Replay:

The webcast will be archived for three months on the Company’s Investor Relations section of its website at:
https://ir.stevanatogroup.com/financial-results

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. For more information, please visit www.stevanatogroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231017393927/en/

Investor Relations

Lisa Miles

lisa.miles@stevanatogroup.com

Media

media@stevanatogroup.com

Source: Stevanato Group S.p.A.

FAQ

When will Stevanato Group release its Q3 2023 financial results?

Stevanato Group will release its Q3 2023 financial results on October 31, 2023.

What is the purpose of the conference call and webcast?

The conference call and webcast are scheduled to discuss Stevanato Group's financial results.

How can participants gain immediate access to the conference call?

Participants can pre-register for the conference call using the provided link to receive a conference passcode and unique PIN for immediate access.

Where can the webcast be accessed?

The webcast can be accessed at the provided link.

Will the webcast be available for replay?

Yes, the webcast will be archived for three months on Stevanato Group's Investor Relations section of its website.